Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors

AbstractObjective A meta-analysis was conducted to assess the efficacy and safety of cryoablation (CRA) compared with radiofrequency ablation (RFA).Methods A systematic search of PubMed, EMBASE, Cochrane Library, Wanfang, CNKI, and VIP databases was conducted to identify clinical controlled studies...

Full description

Bibliographic Details
Main Authors: Xiangzhong Huang, Xinjian Xu, Hongtao Du, Qiulian Sun, Minyu Wu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:International Journal of Hyperthermia
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/02656736.2023.2300347
_version_ 1797361509867716608
author Xiangzhong Huang
Xinjian Xu
Hongtao Du
Qiulian Sun
Minyu Wu
author_facet Xiangzhong Huang
Xinjian Xu
Hongtao Du
Qiulian Sun
Minyu Wu
author_sort Xiangzhong Huang
collection DOAJ
description AbstractObjective A meta-analysis was conducted to assess the efficacy and safety of cryoablation (CRA) compared with radiofrequency ablation (RFA).Methods A systematic search of PubMed, EMBASE, Cochrane Library, Wanfang, CNKI, and VIP databases was conducted to identify clinical controlled studies comparing CRA versus RFA for hepatic malignancies up to July 2022. The meta-analysis was performed using RevMan 5.3.Results A comprehensive analysis was conducted on 8 clinical controlled studies involving a total of 943 patients. There were no significant differences in the incidence of complications, complete ablation of lesions, local recurrence, and 1-year survival between the CRA and RFA groups (OR = 0.98, 95%CI: 0.61–1.55, p = 0.92; OR = 1.08, 95%CI: 0.62–1.90, p = 0.78; OR = 1.28, 95%CI: 0.49–3.36, p = 0.61; and OR = 1.14, 95%CI: 0.63–2.06, p = 0.66, respectively).Conclusion The efficacy and safety profile of CRA was comparable to that of RFA in the context of ablation therapy for hepatic malignancies. These findings suggested that CRA may be a valuable alternative to RFA in the treatment of hepatic malignancies.
first_indexed 2024-03-08T15:54:42Z
format Article
id doaj.art-6e29dfd506e8462ab18281d12e3e2964
institution Directory Open Access Journal
issn 0265-6736
1464-5157
language English
last_indexed 2024-03-08T15:54:42Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series International Journal of Hyperthermia
spelling doaj.art-6e29dfd506e8462ab18281d12e3e29642024-01-08T22:38:16ZengTaylor & Francis GroupInternational Journal of Hyperthermia0265-67361464-51572024-12-0141110.1080/02656736.2023.2300347Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumorsXiangzhong Huang0Xinjian Xu1Hongtao Du2Qiulian Sun3Minyu Wu4Department of Interventional Radiology, Jiangyin Hospital Affiliated to Nantong University, Jiangyin City, Jiangsu Province, ChinaDepartment of Interventional Radiology, Jiangyin Hospital Affiliated to Nantong University, Jiangyin City, Jiangsu Province, ChinaDepartment of Radiology, Xuzhou Central Hospital, Xuzhou City, Jiangsu Province, ChinaDepartment of Radiology, The Fifth People’s Hospital of Suzhou, Suzhou City, Jiangsu Province, ChinaDepartment of Radiology, The Fifth People’s Hospital of Suzhou, Suzhou City, Jiangsu Province, ChinaAbstractObjective A meta-analysis was conducted to assess the efficacy and safety of cryoablation (CRA) compared with radiofrequency ablation (RFA).Methods A systematic search of PubMed, EMBASE, Cochrane Library, Wanfang, CNKI, and VIP databases was conducted to identify clinical controlled studies comparing CRA versus RFA for hepatic malignancies up to July 2022. The meta-analysis was performed using RevMan 5.3.Results A comprehensive analysis was conducted on 8 clinical controlled studies involving a total of 943 patients. There were no significant differences in the incidence of complications, complete ablation of lesions, local recurrence, and 1-year survival between the CRA and RFA groups (OR = 0.98, 95%CI: 0.61–1.55, p = 0.92; OR = 1.08, 95%CI: 0.62–1.90, p = 0.78; OR = 1.28, 95%CI: 0.49–3.36, p = 0.61; and OR = 1.14, 95%CI: 0.63–2.06, p = 0.66, respectively).Conclusion The efficacy and safety profile of CRA was comparable to that of RFA in the context of ablation therapy for hepatic malignancies. These findings suggested that CRA may be a valuable alternative to RFA in the treatment of hepatic malignancies.https://www.tandfonline.com/doi/10.1080/02656736.2023.2300347Malignant liver tumorcryoablationradiofrequency ablationmeta-analysis
spellingShingle Xiangzhong Huang
Xinjian Xu
Hongtao Du
Qiulian Sun
Minyu Wu
Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors
International Journal of Hyperthermia
Malignant liver tumor
cryoablation
radiofrequency ablation
meta-analysis
title Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors
title_full Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors
title_fullStr Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors
title_full_unstemmed Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors
title_short Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors
title_sort meta analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors
topic Malignant liver tumor
cryoablation
radiofrequency ablation
meta-analysis
url https://www.tandfonline.com/doi/10.1080/02656736.2023.2300347
work_keys_str_mv AT xiangzhonghuang metaanalysisofcryoablationversusradiofrequencyablationinthetreatmentofmalignantlivertumors
AT xinjianxu metaanalysisofcryoablationversusradiofrequencyablationinthetreatmentofmalignantlivertumors
AT hongtaodu metaanalysisofcryoablationversusradiofrequencyablationinthetreatmentofmalignantlivertumors
AT qiuliansun metaanalysisofcryoablationversusradiofrequencyablationinthetreatmentofmalignantlivertumors
AT minyuwu metaanalysisofcryoablationversusradiofrequencyablationinthetreatmentofmalignantlivertumors